More successes in iPS cell research from down at UCLA.
“I believe iPS cells address many of the shortcomings of human embryonic stem cells and are the future of regenerative medicine,” said MacLellan, an associate professor of cardiology and physiology. “I’m hoping that these scientific findings are the first step towards one day developing new therapies that I can offer my patients. There are still many limitations with using iPS cells in clinical studies that we must overcome, but there are scientists in labs across the country working to address these issues right now.”
Author Profile
- Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.
Latest entries
FeaturedOctober 16, 2024Brava Italia! Jennifer Lahl, founder The Center for Bioethics and Culture
FeaturedSeptember 9, 2024Don’t Make Claims Using Outdated Data
BioethicsMay 16, 2024The Ethics of Transplantation Medicine
infertilityApril 23, 2024The Rise of International Gestational Surrogacy in the U.S.
